Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling

Frontiers in Physiology

Volumn 3 SEP, Issue , 2012, Pages

  Alberghina, Lilia ^a,b   Gaglio, Daniela ^a,b,c   Gelfi, Cecilia ^a,c   Moresco, Rosa M ^a,b,c   Mauri, Giancarlo ^a,b   Bertolazzi, Paola ^a,d   Messa, Cristina ^a,b,c   Gilardi, Maria C ^a,b,c   Chiaradonna, Ferdinando ^a,b   Vanoni, Marco ^a,b  

^a Milano and Rome   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

^d CNR   (Italy)

Author keywords

Cancer research; Emergent properties; Metabolism; Mitochondrial dysfunction; Systems biology

Indexed keywords

EID: 84867123432     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00362     Document Type: Article

References (262)

1. Abadi, A., Glover, E. I., Isfort, R. J., Raha, S., Safdar, A., Yasuda, N., Kaczor, J. J., Melov, S., Hubbard, A., Qu, X., Phillips, S. M., and Tarnopolsky, M. (2009). Limb immobilization induces a coordinate down-regulation of mitochondrial and other metabolic pathways in men and women. PLoS ONE 4:e6518. doi: 10.1371/ journal.pone.0006518
2. Abercrombie, M. (1979). Contact inhibition and malignancy. Nature 281, 259-262.
3. Acin-Perez, R., Salazar, E., Kamenetsky, M., Buck, J., Levin, L. R., and Manfredi, G. (2009). Cyclic AMP produced inside mitochondria regulates oxidative phosphorylation. Cell Metab. 9, 265-276.
4. Alberghina, L., Coccetti, P., and Orlandi, I. (2009). Systems biology of the cell cycle of Saccharomyces cerevisiae: from network mining to system-level properties. Biotechnol. Adv. 27, 960-978.
5. Alberghina, L., Mavelli, G., Drovandi, G., Palumbo, P., Pessina, S., Tripodi, F., Coccetti, P., and Vanoni, M. (2012). Cell growth and cell cycle in Saccharomyces cerevisiae: basic regulatory design and protein-protein interaction network. Biotechnol. Adv. 30, 52-72.
6. Alberghina, L., Porro, D., and Cazzador, L. (2001). Towards a blueprint of the cell cycle. Oncogene 20, 1128-1134.
7. Alberghina, L., and Westerhoff, H. (2005). Systems Biology: Definitions and Perspectives, (topics in current genetics). Heidelberg: Springer.
8. Aldea, M., Clofent, J., Nunez de Arenas C.,Chamorro,M.,Velasco,M., Berrendero, J. R., Navarro, C., and Cuezva, J. M. (2011). Reverse phase protein microarrays quantify and validate the bioenergetic signature as biomarker in colorectal cancer. Cancer Lett. 311, 210-218.
9. Alfieri, R., Barberis, M., Chiaradonna, F., Gaglio, D., Milanesi, L., Vanoni, M., Klipp, E., and Alberghina, L. (2009). Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation. BMC Bioinformatics 10(Suppl. 12), S16.
10. Anastasiou, D., and Cantley, L. C. (2012). Breathless cancer cells get fat on glutamine. Cell Res. 22, 443-446.
11. Arnesen, T., Van Damme, P., Polevoda, B., Helsens, K., Evjenth, R., Colaert, N., Varhaug, J. E., Vandekerckhove, J., Lillehaug, J. R., Sherman, F., and Gevaert, K. (2009). Proteomics analyses reveal the evolutionary conservation and divergence of N-terminal acetyltransferases from yeast and humans. Proc. Natl. Acad. Sci. U.S.A. 106, 8157-8162.
12. Aukema, T. S., Kappers, I., Olmos, R. A., Codrington, H. E., van Tinteren H.,vanPel,R.,andKlomp,H. M. (2010). Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer? J. Nucl. Med. 51, 1344-1348.
13. Baines, C. P., Kaiser, R. A., Sheiko T., Craigen, W.J., and Molkentin, J. D. (2007). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9, 550-555.
14. Balestrieri, C., Alberghina, L., Vanoni, M., and Chiaradonna, F. (2009). Data recovery and integration from public databases uncovers transformation-specific transcriptional downregulation of cAMP-PKA pathway-encoding genes. BMC Bioinformatics 10(Suppl. 12), S1.
15. Balestrieri, C., Vanoni, M., Hautaniemi, S., Alberghina, L., and Chiaradonna, F. (2012). Integrative transcriptional analysis between human and mouse cancer cells provides a common set of transformation associated genes. Biotechnol. Adv. 30, 16-29.
16. Baracca, A., Chiaradonna, F., Sgarbi, G., Solaini, G., Alberghina, L., and Lenaz, G. (2010). Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells. Biochim. Biophys. Acta 1797, 314-323.
17. Barberis, M., Klipp, E., Vanoni, M., and Alberghina, L. (2007). Cell size at S phase initiation: an emergent property of the G1/S network. PLoS Comput. Biol. 3:e64. doi: 10.1371/journal.pcbi.0030064
18. Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland J.M.,Lukas,C.,Orntoft,T., Lukas, J., and Bartek, J. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870.
19. Beck, M., Schmidt, A., Malmstroem, J., Claassen, M., Ori, A., Szymborska, A., Herzog, F., Rinner, O., Ellenberg, J., and Aebersold, R. (2011). The quantitative proteome of a human cell line. Mol. Syst. Biol. 7, 549.
20. Bellis, A., Castaldo, D., Trimarco V.,Monti,M.G.,Chivasso,P., Sadoshima,J.,Trimarco,B.,and Morisco, C. (2009). Cross-talk between PKA and Akt protects endothelial cells from apoptosis in the late ischemic preconditioning. Arterioscler. Thromb. Vasc. Biol. 29, 1207-1212.
21. Ben-Menachem, R., Tal, M., Shadur, T., and Pines, O. (2011). A third of the yeast mitochondrial proteome is dual localized: a question of evolution. Proteomics 11, 4468-4476.
22. Benard, G., Bellance, N., James, D., Parrone, P., Fernandez, H., Letellier, T., and Rossignol, R. (2007). Mitochondrial bioenergetics and structural network organization. J. Cell. Sci. 120(Pt 5), 838-848.
23. Bhalla, U. S., and Iyengar, R. (1999). Emergent properties of networks of biological signaling pathways. Science 283, 381-387.
24. Bonnet, S., Archer, S. L., AllalunisTurner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet,S.,Harry,G.,Hashimoto, K.,Porter,C.J.,Andrade,M.A., Thebaud, B., and Michelakis, E. D. (2007). A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37-51.
25. Boren, J., Cascante, M., Marin, S., Comin-Anduix, B., Centelles, J. J., Lim, S., Bassilian, S., Ahmed, S., Lee, W. N., and Boros, L. G. (2001). Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J. Biol. Chem. 276, 37747-37753.
26. Bos, J. L. (1989). ras oncogenes in human cancer: a review. Cancer Res. 49, 4682-4689.
27. Bossu, P., Vanoni, M., Wanke, V., Cesaroni,M.P.,Tropea,F.,Melillo, G.,Asti,C.,Porzio,S.,Ruggiero, P., Di Cioccio, V., Maurizi, G., Ciabini, A., and Alberghina, L. (2000). A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts. Oncogene 19, 2147-2154.
28. Bottoni, P., Giardina, B., Pontoglio A., Scara, S.,andScatena,R. (2012). Mitochondrial proteomic approaches for new potential diagnostic and prognostic biomarkers in cancer. Adv. Exp. Med. Biol. 942, 423-440.
29. Bruggeman, F. J., Snoep, J. L., and Westerhoff, H. V. (2008). Control, responses and modularity of cellular regulatory networks: a control analysis perspective. IET Syst. Biol. 2, 397-410.
30. Brummer, A., Salazar, C., Zinzalla, V., Alberghina, L., and Hofer, T. (2010). Mathematical modelling of DNA replication reveals a trade-off between coherence of origin activation and robustness against rereplication. PLoS Comput. Biol. 6:e1000783. doi: 10.1371/journal.pcbi.1000783
31. Burte, F., De Girolamo, L. A. Hargreaves,A.J.,andBillett, E. E. (2011). Alterations in the mitochondrial proteome of neuroblastoma cells in response to complex 1 inhibition. J. Proteome Res. 10, 1974-1986.
32. Cavaliere, B., Macchione, B., Monteleone, M., Naccarato, A. Sindona, G., and Tagarelli, A. (2011). Sarcosine as a marker in prostate cancer progression: a rapid and simple method for its quantification in human urine by solid-phase microextraction-gas chromatography-triple quadrupole mass spectrometry. Anal. Bioanal. Chem. 400, 2903-2912.
33. Chang, C. R., and Blackstone, C. (2007). Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J. Biol. Chem. 282, 21583-21587.
34. Chang, I., Heiske, M., Letellier, T., Wallace, D., and Baldi, P. (2011). Modeling of mitochondria bioenergetics using a composable chemiosmotic energy transduction rate law: theory and experimental validation. PLoS ONE 6:e14820. doi: 10.1371/journal.pone.0014820
35. Chen, V., and Shtivelman, E. (2010). CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation. Cell Cycle 9, 4941-4953.
36. Chen, Y., Craigen, W. J., and Riley, D. J. (2009). Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. Cell Cycle 8, 257-267.
37. Chen,Y.W.,Chou,H.C.,Lyu,P.C., Yin,H.S.,Huang,F.L.,Chang, W.S.,Fan,C.Y.,Tu,I.F.,Lai, T.C.,Lin,S.T.,Lu,Y.C.,Wu, C. L., Huang, S. H., and Chan, H. L. (2011). Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers. Funct. Integr. Genomics 11, 225-239.
38. Chiaradonna, F., Moresco, R. M., Airoldi, C., Gaglio, D., Palorini, R., Nicotra, F., Messa, C., and Alberghina, L. (2012). From cancer metabolism to new biomarkers and drug targets. Biotechnol. Adv. 30, 30-51.
39. Chiaradonna, F., Sacco, E., Manzoni, R., Giorgio, M., Vanoni, M., and Alberghina, L. (2006). Rasdependent carbon metabolism and transformation in mouse fibroblasts. Oncogene 25, 5391-5404.
40. Chun, S. Y., Johnson, C., Washburn, J. G., Cruz-Correa, M. R., Dang, D. T., and Dang, L. H. (2010). Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF1alpha and HIF-2alpha target genes. Mol. Cancer 9, 293.
41. Chung,Y.L.,Troy,H.,Banerji,U., Jackson, L. E., Walton, M. I. Stubbs, M., Griffiths, J. R., Judson, I. R., Leach, M. O., Workman, P., and Ronen, S. M. (2003). Magnetic resonance spectroscopic pharmacodynamic markers of the heat shock protein 90 inhibitor 17-allylamino, 17-demethoxygeldanamycin (17AAG) in human colon cancer models. J. Natl. Cancer Inst. 95, 1624-1633.
42. Cloutier,M.,Bolger,F.B.,Lowry,J. P., and Wellstead, P. (2009). An integrative dynamic model of brain energy metabolism using in vivo neurochemical measurements. J. Comput. Neurosci. 27, 391-414.
43. Cloutier, M., and Wellstead, P. (2010). The control systems structures of energy metabolism. J. R. Soc. Interface 7, 651-665.
44. Codogno, P., and Meijer, A. J. (2005). Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12(Suppl. 2), 1509-1518.
45. Cortassa, S., and Aon, M. A. (2012). Computational modeling of mitochondrial function. Methods Mol. Biol. 810, 311-326.
46. Cox, A. D., and Der, C. J. (2003). The dark side of Ras: regulation of apoptosis. Oncogene 22, 8999-9006.
47. Cribbs, J. T., and Strack, S. (2007). Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep. 8, 939-944.
48. Cui, Q. (2010). A network of cancer genes with co-occurring and anti-co-occurring mutations. PLoS ONE 5:e13180. doi: 10.1371/ journal.pone.0013180
49. Cullinane, C., Dorow, D. S., Kansara, M., Conus, N., Binns, D., Hicks, R. J., Ashman, L. K., McArthur, G. A., and Thomas, D. M. (2005). An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer Res. 65, 9633-9636.
50. Da Cruz, S., Parone, P. A., and Martinou, J. C. (2005). Building the mitochondrial proteome. Expert Rev. Proteomics 2, 541-551.
51. Dagda,R.K.,Gusdon,A.M.,Pien, I., Strack, S., Green, S., Li, C., Van Houten, B., Cherra, S. J. 3rd., and Chu, C. T. (2011). Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ. 18, 1914-1923.
52. Dang,L.,White,D.W.,Gross,S.,Bennett, B.D.,Bittinger,M.A.,Driggers,E. M.,Fantin,V.R.,Jang,H.G.,Jin,S., Keenan, M. C., Marks, K. M., Prins, R. M., Ward, P. S., Yen, K. E., Liau L. M., Rabinowitz, J. D., Cantley, L. C., Thompson, C. B., Vander Heiden, M. G., and Su, S. M. (2009). Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744.
53. de Groof, A. J., te Lindert, M. M., van Dommelen, M. M., Wu M.,Willemse,M.,Smift,A.L., Winer, M., Oerlemans, F., Pluk H.,Fransen,J.A.,andWieringa, B. (2009). Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype. Mol. Cancer 8, 54.
54. De Pinto, V., Messina, A., Lane, D. J., and Lawen, A. (2010). Voltagedependent anion-selective channel (VDAC) in the plasma membrane. FEBS Lett. 584, 1793-1799.
55. De Rasmo, D., Signorile, A., Larizza, M., Pacelli, C., Cocco, T., and Papa, S. (2011). Activation of the cAMP cascade in human fibroblast cultures rescues the activity of oxidatively damaged complex I. Free Radic. Biol. Med. 52, 757-764.
56. DeRasmo,D.,Signorile,A.,Roca,E., and Papa, S. (2009). cAMP response element-binding protein (CREB) is imported into mitochondria and promotes protein synthesis. FEBS J. 276, 4325-4333.
57. DeBerardinis, R. J., and Cheng, T. (2010). Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29, 313-324.
58. Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre, M., Nuciforo, P. G., Bensimon, A., Maestro, R., Pelicci, P. G., and d'Adda di Fagagna, F. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642.
59. Distler, A. M., Kerner, J., and Hoppel, C. L. (2007). Post-translational modifications of rat liver mitochondrial outer membrane proteins identified by mass spectrometry. Biochim. Biophys. Acta 1774, 628-636.
60. Distler, A. M., Kerner, J., and Hoppel, C. L. (2008). Proteomics of mitochondrial inner and outer membranes. Proteomics 8, 4066-4082.
61. Downward, J. (2003). Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22.
62. Drosten, M., Dhawahir, A., Sum E.Y.,Urosevic,J.,Lechuga,C. G., Esteban, L. M., Castellano, E., Guerra, C., Santos, E., and Barbacid, M. (2010). Genetic analysis of Ras signalling pathways in cell proliferation, migrationand survival. EMBO J. 29, 1091-1104.
63. Eagle, H., and Levine, E. M. (1967). Growth regulatory effects of cellular interaction. Nature 213, 1102-1106.
64. Eisenberg, D., Marcotte, E. M., Xenarios, I., and Yeates, T. O. (2000). Protein function in the post-genomic era. Nature 405, 823-826.
65. Fabian, C., Koetz, L., Favaro, E., Indraccolo, S., Mueller-Klieser, W., and Sattler, U. G. (2012). Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts. FEBS J. 279, 882-891.
66. Fagotto,F.,andGumbiner,B.M. (1996). Cell contact-dependent signaling. Dev. Biol. 180, 445-454.
67. Fantin, V. R., St-Pierre, J., and Leder, P. (2006). Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9, 425-434.
68. Fell, D. L., and Black, B. (1997). Driver fatigue in the city. Accid. Anal. Prev. 29, 463-469.
69. Ferbeyre, G., de Stanchina, E., Lin, A. W., Querido, E., McCurrach, M. E., Hannon, G. J., and Lowe, S. W. (2002). Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 22, 3497-3508.
70. Fiordalisi,J.J.,Holly,S.P.,Johnson,R. L. 2nd., Parise, L. V., and Cox, A. D. (2002). A distinct class of dominant negative Ras mutants: cytosolic GTP-bound Ras effector domain mutants that inhibit Ras signaling and transformation and enhance cell adhesion. J. Biol. Chem. 277, 10813-10823.
71. Fischer, E., and Sauer, U. (2003). Metabolic flux profiling of Escherichia coli mutants in central carbon metabolism using GC-MS. Eur. J. Biochem. 270, 880-891.
72. Ford, B., Boykevisch, S., Zhao, C., Kunzelmann, S., Bar-Sagi, D., Herrmann, C., and Nassar, N. (2009). Characterization of a Ras mutant with identical GDPand GTP-bound structures. Biochemistry 48, 11449-11457.
73. Fritz, K. S., Galligan, J. J., Hirschey, M. D., Verdin, E., and Petersen, D. R. (2012). Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice. J. Proteome Res. 11, 1633-1643.
74. Fritz, V., and Fajas, L. (2010). Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene 29, 4369-4377.
75. Fuhrer, T., Fischer, E., and Sauer, U. (2005). Experimental identification and quantification of glucose metabolism in seven bacterial species. J. Bacteriol. 187, 1581-1590.
76. Fulda, S., Galluzzi, L., and Kroemer, G. (2010). Targeting mitochondria forcancertherapy.Nat. Rev. Drug Discov. 9, 447-464.
77. Gabaldon,T.,andHuynen,M.A. (2004). Shaping the mitochondrial proteome. Biochim. Biophys. Acta 1659, 212-220.
78. Gaglio, D., Metallo, C. M., Gameiro P.A.,Hiller,K.,Danna,L.S., Balestrieri, C., Alberghina, L., Stephanopoulos, G., and Chiaradonna, F. (2011). Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol. Syst. Biol. 7, 523.
79. Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L., and Chiaradonna, F. (2009). Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS ONE 4:e4715. doi: 10.1371/journal.pone.0004715
80. Gallagher, F. A., Kettunen, M. I., Day, S. E., Hu, D. E., Karlsson, M., Gisselsson, A., Lerche, M. H., and Brindle, K. M. (2011). Detection of tumor glutamate metabolism in vivo using (13)C magnetic resonance spectroscopy and hyperpolarized [1-(13)C]glutamate. Magn. Reson. Med. 66, 18-23.
81. Gallagher, F. A., Kettunen, M. I., Day, S. E., Lerche, M., and Brindle, K. M. (2008). 13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13Clabeled glutamine. Magn. Reson. Med. 60, 253-257.
82. Galluzzi, L., Kepp, O., and Kroemer, G. (2011). Mitochondrial dynamics: a strategy for avoiding autophagy. Curr. Biol. 21, R478-R480.
83. Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., Gottlieb, E., Green, D. R., Hengartner, M. O., Kepp, O., Knight, R. A., Kumar, S., Lipton S.A.,Lu,X.,Madeo,F.,Malorni, W.,Mehlen,P.,Nunez,G.,Peter, M. E., Piacentini, M., Rubinsztein D.C.,Shi,Y.,Simon,H.U., Vandenabeele, P., White, E., Yuan, J.,Zhivotovsky,B.,Melino,G.,and Kroemer, G. (2012). Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death (2012). Cell Death Differ. 19, 107-120.
84. Garcia-Cao, I., Song, M. S., Hobbs, R. M., Laurent, G., Giorgi, C., de Boer, V. C., Anastasiou, D., Ito, K., Sasaki, A. T., Rameh, L., Carracedo, A., Vander Heiden, M. G.,Cantley,L.C.,Pinton,P., Haigis,M.C.,andPandolfi,P. P. (2012). Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 149, 49-62.
85. Gelfi, C., and De Palma, S. (2012). 2D DIGE analysis of protein extracts from muscle tissue. Methods Mol. Biol. 854, 155-168.
86. Gennemark, P., Nordlander, B., Hohmann, S., and Wedelin, D. (2006). A simple mathematical model of adaptation to high osmolarity in yeast. In Silico Biol. 6, 193-214.
87. Gewies, A. (2003). Introduction to apoptosis. ApoReview. 1-26. Available online at: http://www.celldeath.de/encyclo/aporev/apointro.pdf
88. Gianazza, E., Eberini, I., Sensi, C., Barile, M., Vergani, L., and Vanoni, M. A. (2011). Energy matters: mitochondrial proteomics for biomedicine. Proteomics 11, 657-674.
89. Goetze, S., Qeli, E., Mosimann, C., Staes, A., Gerrits, B., Roschitzki B.,Mohanty,S.,Niederer,E. M.,Laczko,E.,Timmerman,E., Lange, V., Hafen, E., Aebersold, R., Vandekerckhove, J., Basler, K., Ahrens, C. H., Gevaert, K., and Brunner, E. (2009). Identification and functional characterization of N-terminally acetylated proteins in Drosophila melanogaster. PLoS Biol. 7:e1000236. doi: 10.1371/journal.pbio.1000236
90. Gorgoulis, V. G., Vassiliou, L. V., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., Ditullio, R. A. Jr., Kastrinakis, N. G., Levy, B., Kletsas, D., Yoneta, A., Herlyn, M., Kittas, C., and Halazonetis, T. D. (2005). Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913.
91. Greaves, M., and Maley, C. C. (2012). Clonal evolution in cancer. Nature 481, 306-313.
92. Griffin, J. L., and Shockcor, J. P. (2004). Metabolic profiles of cancer cells. Nat. Rev. Cancer 4, 551-561.
93. Guo, J. Y., Chen, H. Y., Mathew, R., Fan, J., Strohecker, A. M., KarsliUzunbas, G., Kamphorst, J. J. Chen, G., Lemons, J. M., Karantza V.,Coller,H.A.,Dipaola,R.S., Gelinas, C., Rabinowitz, J. D., and White, E. (2011). Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25, 460-470.
94. Haberkorn, U., Markert, A., Mier W.,Askoxylakis,V.,andAltmann, A. (2011). Molecular imaging of tumor metabolism and apoptosis. Oncogene 30, 4141-4151.
95. Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
96. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
97. Harada, H., Becknell, B., Wilm, M., Mann, M., Huang, L. J., Taylor, S. S., Scott, J. D., and Korsmeyer, S. J. (1999). Phosphorylation and inactivation of BAD by mitochondriaanchored protein kinase A. Mol. Cell 3, 413-422.
98. Hartwell, L. H., Hopfield, J. J., Leibler, S., and Murray, A. W. (1999). From molecular to modular cell biology. Nature 402(Suppl. 6761), C47-C52.
99. Hedin, L., and Rosberg, S. (1983). Forskolin effects on the cAMP system and steroidogenesis in the immature rat ovary. Mol. Cell. Endocrinol. 33, 69-80.
100. Henney, A., and Superti-Furga, G. (2008). A network solution. Nature 455, 730-731.
101. Herrmann, P. C., Gillespie, J. W., Charboneau, L., Bichsel, V. E., Paweletz, C. P., Calvert, V. S., Kohn, E. C., Emmert-Buck, M. R., Liotta, L. A., and Petricoin, E. F. 3rd. (2003). Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3, 1801-1810.
102. Hiller, K., Hangebrauk, J., Jager, C., Spura, J., Schreiber, K., and Schomburg, D. (2009). MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Anal. Chem. 81, 3429-3439.
103. Hiller, K., Metallo, C., and Stephanopoulos, G. (2011). Elucidation of cellular metabolism via metabolomics and stableisotope assisted metabolomics. Curr. Pharm. Biotechnol. 12, 1075-1086.
104. Hiller, K., Metallo, C. M., Kelleher, J. K., and Stephanopoulos, G. (2010). Nontargeted elucidation of metabolic pathways using stable-isotope tracers and mass spectrometry. Anal.Chem. 82, 6621-6628.
105. Hiraki, Y., McMorrow, I. M., and Birnbaum, M. J. (1989). The regulation of glucose transporter gene expression by cyclic adenosine monophosphate in NIH3T3 fibroblasts. Mol. Endocrinol. 3, 1470-1476.
106. Holley, R. W., and Kiernan, J. A. (1968). "Contact inhibition" of cell division in 3T3 cells. Proc. Natl. Acad. Sci. U.S.A. 60, 300-304.
107. Honer, M., Ebenhan, T., Allegrini, P. R., Ametamey, S. M., Becquet, M., Cannet, C., Lane, H. A., O'Reilly T.M.,Schubiger,P.A.,StickerJantscheff, M., Stumm, M., and McSheehy, P. M. (2010). AntiAngiogenic/Vascular Effects of the mTOR Inhibitor Everolimus Are Not Detectable by FDG/FLT-PET. Transl. Oncol. 3, 264-275.
108. Horan, M. P., Pichaud, N., and Ballard, J. W. (2012). Review: quantifying mitochondrial dysfunction in complex diseases of aging. J. Gerontol. A Biol. Sci. Med. Sci. doi: 10.1093/gerona/glr263. [Epub ahead of print].
109. Hornberg, J. J., Bruggeman, F. J., Westerhoff, H. V., and Lankelma, J. (2006). Cancer: a systems biology disease. Biosystems 83, 81-90.
110. Hosaka, Y., Tawata, M., Kurihara, A., Ohtaka, M., Endo, T., and Onaya, T. (1992). The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 131, 159-165.
111. Hu, H., Deng, C., Yang, T., Dong, Q., Chen,Y.,Nice,E.C.,Huang,C.,and Wei, Y. (2011). Proteomics revisits the cancer metabolome. Expert Rev. Proteomics 8, 505-533.
112. Hu,W.,Zhang,C.,Wu,R.,Sun, Y.,Levine,A.,andFeng,Z. (2010). Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. U.S.A. 107, 7455-7460.
113. Huber, H. J., Dussmann, H., Kilbride, S. M., Rehm, M., and Prehn, J. H. (2011). Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release. Mol. Syst. Biol. 7, 470.
114. Icard,P.,Poulain,L.,andLincet,H. (2012). Understanding the central role of citrate in the metabolism of cancer cells. Biochim. Biophys. Acta 1825, 111-116.
115. Joyce, A. R., and Palsson, B. O. (2006). The model organism as a system: integrating 'omics' data sets. Nat. Rev. Mol. Cell Biol. 7, 198-210.
116. Kaizu, K., Ghosh, S., Matsuoka, Y., Moriya, H., Shimizu-Yoshida, Y., and Kitano, H. (2010). A comprehensive molecular interaction map of the budding yeast cell cycle. Mol. Syst. Biol. 6, 415.
117. Kalinina, J., Carroll, A., Wang, L., Yu, Q., Mancheno, D. E., Wu, S., Liu, F., Ahn, J., He, M., Mao, H., and Van Meir, E. G. (2012). Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma. J. Mol. Med. (Berl.). doi: 10.1007/ s00109-012-0888-x. [Epub ahead of print].
118. Kang,U.B.,Yeom,J.,Kim,H.J.,Kim, H., and Lee, C. (2012). Expression profiling of more than 3500 proteins of MSS-type colorectal cancer by stable isotope labeling and mass spectrometry. J. Proteomics. 75, 3050-3062.
119. Kao, J., Salari, K., Bocanegra, M., Choi, Y. L., Girard, L., Gandhi, J., Kwei, K. A., Hernandez-Boussard, T., Wang, P.,Gazdar,A.F.,Minna,J.D.,and Pollack, J. R. (2009). Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery. PLoS ONE 4:e6146. doi: 10.1371/journal.pone.0006146
120. Kerner, J., Lee, K., Tandler, B., and Hoppel, C. L. (2011). VDAC proteomics: post-translation modifications. Biochim. Biophys. Acta. 1818, 1520-1525.
121. Khalil, I. G., and Hill, C. (2005). Systems biology for cancer. Curr. Opin. Oncol. 17, 44-48.
122. Kim, S. C., Sprung, R., Chen, Y. Xu,Y.,Ball,H.,Pei,J.,Cheng, T., Kho, Y., Xiao, H., Xiao, L., Grishin, N. V., White, M., Yang, X. J., and Zhao, Y. (2006). Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23, 607-618.
123. Kitano, H. (2002). Systems biology: a brief overview. Science 295, 1662-1664.
124. Kitano, H. (2010). Grand challenges in systems physiology. Front. Physiol. 1:3. doi:10.3389/fphys.2010.00003
125. Klipp, E., Nordlander, B., Kruger, R., Gennemark, P., and Hohmann, S. (2005). Integrative model of the response of yeast to osmotic shock. Nat. Biotechnol. 23, 975-982.
126. Koivunen, P., Lee, S., Duncan, C. G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J. A., Joensuu, P., Bergmann, U., Gross, S., Travins, J., Weiss, S., Looper, R., Ligon, K. L. Verhaak, R. G., Yan, H., and Kaelin, W. G. Jr. (2012). Transformation by the (R)-enantiomer of 2hydroxyglutarate linked to EGLN activation. Nature 483, 484-488.
127. Konstantinopoulos, P. A., Karamouzis M.V.,andPapavassiliou,A.G. (2007). Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat. Rev. Drug Discov. 6, 541-555.
128. Koopman,W.J.,Visch,H.J.,Verkaart, S., van den Heuvel, L. W., Smeitink, J. A., and Willems, P. H. (2005). Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am.J.Physiol.CellPhysiol. 289, C881-C890.
129. Koorstra,J.B.,Hong,S.M.,Shi,C., Meeker, A. K., Ryu, J. K., Offerhaus, G. J., Goggins, M. G., Hruban, R. H., and Maitra, A. (2009). Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia. Mod. Pathol. 22, 1439-1445.
130. Koppenol, W. H., Bounds, P. L., and Dang, C. V. (2011). Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325-337.
131. Korzeniewski, B., and Zoladz, J. A. (2001). A model of oxidative phosphorylation in mammalian skeletal muscle. Biophys. Chem. 92, 17-34.
132. Kreeger, P. K., and Lauffenburger, D. A. (2010). Cancer systems biology: a network modeling perspective. Carcinogenesis 31, 2-8.
133. Krieg, R. C., Knuechel, R., Schiffmann, E., Liotta, L. A., Petricoin, E. F. 3rd., and Herrmann, P. C. (2004). Mitochondrial proteome: canceraltered metabolism associated with cytochrome c oxidase subunit level variation. Proteomics 4, 2789-2795.
134. Kuppers, M., Ittrich, C., Faust, D., and Dietrich, C. (2010). The transcriptional programme of contactinhibition. J. Cell. Biochem. 110, 1234-1243.
135. Lam, M. P., Scruggs, S. B., Kim T.Y.,Zong,C.,Lau,E.,Wang, D., Ryan, C. M., Faull, K. F., and Ping, P. (2012). An MRMbased workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. J. Proteomics. 75, 4602-4609
136. LaTulippe, E., Satagopan, J., Smith, A., Scher, H., Scardino, P., Reuter, V., and Gerald, W. L. (2002). Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62, 4499-4506.
137. Lauffenburger, D. A. (2000). Cell signaling pathways as control modules: complexity for simplicity? Proc. Natl. Acad. Sci. U.S.A. 97, 5031-5033.
138. Le,A.,Cooper,C.R.,Gouw,A.M., Dinavahi, R., Maitra, A., Deck, L. M.,Royer,R.E.,VanderJagt,D. L., Semenza, G. L., and Dang, C. V. (2010). Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc. Natl. Acad. Sci. U.S.A. 107, 2037-2042.
139. Le,A.,Lane,A.N.,Hamaker,M.,Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., Zimmerman, L. J., Liebler, D. C., Slebos, R. J., Lorkiewicz, P. K.,Higashi,R.M.,Fan,T.W., and Dang, C. V. (2012). Glucoseindependent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110-121.
140. Lee, J. Y., Nagano, Y., Taylor, J. P., Lim, K. L., and Yao, T. P. (2010). Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J. Cell Biol. 189, 671-679.
141. Lefort, N., Yi, Z., Bowen, B., Glancy, B., De Filippis, E. A., Mapes, R., Hwang, H., Flynn, C. R., Willis, W. T., Civitarese, A., Hojlund, K., and Mandarino, L. J. (2009). Proteome profile of functional mitochondria from human skeletal muscle using one-dimensional gel electrophoresis and HPLCESI-MS/MS. J. Proteomics 72, 1046-1060.
142. Lemons, J. M., Feng, X. J., Bennett, B. D., Legesse-Miller, A., Johnson, E. L., Raitman, I., Pollina, E. A., Rabitz, H. A., Rabinowitz, J. D., and Coller, H. A. (2010). Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol. 8:e1000514. doi: 10.1371/journal.pbio.1000514
143. Levine,A.J.,andPuzio-Kuter,A.M. (2010). The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330, 1340-1344.
144. Li, X., Wu, F., Qi, F., and Beard, D. A. (2011). A database of thermodynamic properties of the reactions of glycolysis, the tricarboxylic acid cycle, and the pentose phosphate pathway. Database (Oxford) 2011, bar005.
145. Lian,Z.,DeLuca,P.,andDiCristofano, A. (2006). Gene expression analysis reveals a signature of estrogen receptor activation upon loss of Pten in a mouse model of endometrial cancer. J. Cell. Physiol. 208, 255-266.
146. Lieberman, B. P., Ploessl, K., Wang, L., Qu, W., Zha, Z., Wise, D. R., Chodosh, L. A., Belka, G., Thompson, C. B., and Kung, H. F. (2011). PET imaging of glutaminolysis in tumors by 18F-(2S, 4R)4fluoroglutamine. J. Nucl. Med. 52, 1947-1955.
147. Likic, V. A., McConville, M. J., Lithgow, T., and Bacic, A. (2010). Systems biology: the next frontier for bioinformatics. Adv. Bioinformatics, 268925. doi: 10.1155/2010/268925. [Epub ahead of print].
148. Liou,J.S.,Chen,C.Y.,Chen,J.S.,and Faller, D. V. (2000). Oncogenic ras mediates apoptosis in response to protein kinase C inhibition through the generation of reactive oxygen species. J. Biol. Chem. 275, 39001-39011.
149. Little, M. P. (2010). Cancer models, genomic instability and somatic cellular Darwinian evolution. Biol. Direct 5, 19. discussion 19.
150. Locasale,J.W.,Grassian,A.R.,Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., Sasaki, A. T., Anastasiou, D., Mullarky, E., Vokes, N. I., Sasaki, M., Beroukhim, R., Stephanopoulos, G., Ligon, A. H.,Meyerson,M.,Richardson,A. L., Chin, L., Wagner, G., Asara J.M.,Brugge,J.S.,Cantley,L. C., and Vander Heiden, M. G. (2011). Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43, 869-874.
151. Loeb, K. R., and Loeb, L. A. (2000). Significance of multiple mutations in cancer. Carcinogenesis 21, 379-385.
152. Lombard, D. B., Tishkoff, D. X., and Bao, J. (2011). Mitochondrial sirtuins in the regulation of mitochondrial activity and metabolic adaptation. Handb. Exp. Pharmacol. 206, 163-188.
153. Lu, C., Ward, P. S., Kapoor, G. S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C. R., Khanin, R., Figueroa, M. E., Melnick, A., Wellen, K. E., O'Rourke, D. M., Berger, S. L., Chan, T. A., Levine R.L.,Mellinghoff,I.K.,and Thompson, C. B. (2012). IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483, 474-478.
154. Marino, G., Salvador-Montoliu, N., Fueyo, A., Knecht, E., Mizushima, N., and C. Lopez-Otin. (2007). Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J. Biol. Chem. 282, 18573-18583.
155. Mata, J., Marguerat, S., and Bahler, J. (2005). Post-transcriptional control of gene expression: a genome-wide perspective. Trends Biochem. Sci. 30, 506-514.
156. Mathew,R.,Karp,C.M.,Beaudoin,B., Vuong,N.,Chen,G.,Chen,H.Y.,Bray, K.,Reddy,A.,Bhanot,G.,Gelinas,C., Dipaola,R.S.,Karantza-Wadsworth, V., and White, E. (2009). Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062-1075.
157. Matoba,S.,Kang,J.G.,Patino,W.D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., and Hwang, P. M. (2006). p53 regulates mitochondrial respiration. Science 312, 1650-1653.
158. Mazzanti, R., and Giulivi, C. (2006). Coordination of nuclearand mitochondrial-DNA encoded proteins in cancer and normal colon tissues. Biochim. Biophys. Acta 1757, 618-623.
159. Mazzanti, R., Solazzo, M., Fantappie, O., Elfering, S., Pantaleo, P., Bechi, P., Cianchi, F., Ettl, A., and Giulivi, C. (2006). Differential expression proteomics of human colon cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1329-G1338.
160. Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller K.,Jewell,C.M.,Johnson,Z.R., Irvine, D. J., Guarente, L., Kelleher, J. K., Vander Heiden, M. G., Iliopoulos, O., and Stephanopoulos, G. (2011). Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380-384.
161. Metallo, C. M., Walther, J. L., and Stephanopoulos, G. (2009). Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J. Biotechnol. 144, 167-174.
162. Mitchell, P. (2011). Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. (1966). Biochim. Biophys. Acta 1807, 1507-1538.
163. Modica-Napolitano, J. S., and Singh, K. K. (2004). Mitochondrial dysfunction in cancer. Mitochondrion 4, 755-762.
164. Moreno-Sanchez, R., Saavedra, E., Rodriguez-Enriquez, S., GallardoPerez, J. C., Quezada, H., and Westerhoff, H. V. (2010). Metabolic control analysis indicates a change of strategy in the treatment of cancer. Mitochondrion 10, 626-639.
165. Mueller, C., Liotta, L. A., and Espina, V. (2010). Reverse phase protein microarrays advance to use in clinical trials. Mol. Oncol. 4, 461-481.
166. Nagaraj, N., Wisniewski, J. R., Geiger T.,Cox,J.,Kircher,M.,Kelso, J., Paabo, S., and Mann, M. (2011). Deep proteome and transcriptome mapping of a human cancer cell line. Mol. Syst. Biol. 7, 548.
167. Niemisto, A., Dunmire, V., Yli-Harja, O., Zhang, W., and Shmulevich, I. (2005). Analysis of angiogenesis using in vitro experiments and stochastic growth models. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 72(6 Pt 1), 062902.
168. Noble, D. (2002). The rise of computational biology. Nat. Rev. Mol. Cell Biol. 3, 459-463.
169. Nurse, P., and Hayles, J. (2011). The cell in an era of systems biology. Cell 144, 850-854.
170. Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., and Nakamura, Y. (2001). Genomewide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 61, 2129-2137.
171. Oliva, C. R., Nozell, S. E., Diers, A., McClugage, S. G. 3rd., Sarkaria, J. N.,Markert,J.M.,Darley-Usmar, V. M., Bailey, S. M., Gillespie, G. Y., Landar, A., and Griguer, C. E. (2010). Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J. Biol. Chem. 285, 39759-39767.
172. Oliva, J. L., Zarich, N., Martinez, N., Jorge, R., Castrillo, A., Azanedo, M., Garcia-Vargas, S., Gutierrez-Eisman, S., Juarranz, A., Bosca, L., Gutkind, J. S., and Rojas, J. M. (2004). The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras. J. Biol. Chem. 279, 33480-33491.
173. Osawa, H., Printz, R. L., Whitesell, R. R., and Granner, D. K. (1995). Regulation of hexokinase II gene transcription and glucose phosphorylation by catecholamines, cyclic AMP, and insulin. Diabetes 44, 1426-1432.
174. Palorini, R., De Rasmo, D., Gaviraghi M.,Danna,L.S.,Signorile,A., Cirulli, C., Chiaradonna, F., Alberghina, L., and Papa, S. (2012). Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration. Oncogene. doi: 10.1038/onc.2012.50. [Epub ahead of print].
175. Palumbo, P., Mavelli, G., Farina, L., and Alberghina, L. (2010). Networks and circuits in cell regulation. Biochem. Biophys. Res. Commun. 396, 881-886.
176. Papa, S. (2006). Does cAMP play a part in the regulation of the mitochondrial electron transport chain in mammalian cells? IUBMB Life 58, 173-175.
177. Papa, S., De Rasmo, D., Scacco, S., Signorile, A., Technikova-Dobrova, Z., Palmisano, G., Sardanelli, A. M., Papa, F., Panelli, D., Scaringi, R., and Santeramo, A. (2008). Mammalian complex I: a regulable and vulnerable pacemaker in mitochondrial respiratory function. Biochim. Biophys. Acta 1777, 719-728
178. Papa, S., Rasmo, D. D., TechnikovaDobrova, Z., Panelli, D., Signorile, A., Scacco, S., Petruzzella, V., Papa, F., Palmisano, G., Gnoni, A., Micelli, L., and Sardanelli, A. M. (2011). Respiratory chain complex I, a main regulatory target of the cAMP/PKA pathway is defective in different human diseases. FEBS Lett. 586, 568-577.
179. Parhami, B. (2005). Computer Architecture: From Microprocessors to Supercomputers. New York, NY: Oxford University Press.
180. Piccoli, C., Scacco, S., Bellomo, F., Signorile, A., Iuso, A., Boffoli, D., Scrima, R., Capitanio, N., and Papa, S. (2006). cAMP controls oxygen metabolism in mammalian cells. FEBS Lett. 580, 4539-4543.
181. Pike, L. S., Smift, A. L., Croteau, N. J., Ferrick, D. A., and Wu, M. (2010). Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim. Biophys. Acta. 1807, 726-734.
182. Pylayeva-Gupta, Y., Grabocka, E., and Bar-Sagi, D. (2011). RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11, 761-774.
183. Qu,W.,Oya,S.,Lieberman,B.P., Ploessl, K., Wang, L., Wise, D. R., Divgi, C. R., Chodosh, L. P., Thompson, C. B., and Kung, H. F. (2012). Preparation and characterization of L-[5-11C]glutamine for metabolic imaging of tumors. J. Nucl. Med. 53, 98-105.
184. Qu, W., Zha, Z., Lieberman, B. P., Mancuso, A., Stetz, M., Rizzi, R., Ploessl, K., Wise, D., Thompson, C., and Kung, H. F. (2011). Facile synthesis [5-(13)C-4-(2)H(2)]L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism. Acad. Radiol. 18, 932-939.
185. Rajagopalan, K. N., and DeBerardinis, R. J. (2011). Role of glutamine in cancer: therapeutic and imaging implications. J. Nucl. Med. 52, 1005-1008.
186. Ramakrishna, R., Edwards, J. S., McCulloch, A., and Palsson, B. O. (2001). Flux-balance analysis of mitochondrial energy metabolism: consequences of systemic stoichio metric constraints. Am.J.Physiol. Regul. Integr. Comp. Physiol. 280, R695-R704.
187. Ramanathan, A., Wang, C., and Schreiber, S. L. (2005). Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. U.S.A. 102, 5992-5997.
188. Reuther, G. W., and Der, C. J. (2000). The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr. Opin. Cell Biol. 12, 157-165.
189. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., and Chinnaiyan, A. M. (2004). Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc. Natl. Acad. Sci. U.S.A. 101, 9309-9314.
190. Rivard, N., Boucher, M. J., Asselin, C., and L'Allemain, G. (1999). MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am. J. Physiol. 277(4 Pt 1), C652-C664.
191. Roche, T. E., and Hiromasa, Y. (2007). Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell. Mol. Life Sci. 64, 830-849.
192. Rodenhuis, S. (1992). ras and human tumors. Semin. Cancer Biol. 3, 241-247.
193. Roede, J. R., Park, Y., Li, S., Strobel, F. H., and Jones, D. P. (2012). Detailed mitochondrial phenotyping by high resolution metabolomics. PLoS ONE 7:e33020. doi: 10.1371/journal.pone.0033020
194. Ruan, X., Li, Y., Li, J., Gong, D., and Wang, J. (2006). Tumorspecific gene expression patterns with gene expression profiles. Sci. China C Life Sci. 49, 293-304.
195. Russo, G., Zegar, C., and Giordano, A. (2003). Advantages and limitations of microarray technology in human cancer. Oncogene 22, 6497-6507.
196. Sa, G., and Stacey, D. W. (2004). P27 expression is regulated by separate signaling pathways, downstream of Ras, in each cell cycle phase. Exp. Cell Res. 300, 427-439.
197. Sacco, E., Farina, M., Greco, C., Lamperti, S., Busti, S., Degioia, L., Alberghina, L., Liberati, D., and Vanoni, M. (2012). Regulation of hSos1 activity is a system-level property generated by its multidomain structure. Biotechnol. Adv. 30, 154-168.
198. Salazar, C., Brummer, A., Alberghina, L., and Hofer, T. (2011). Timing control in regulatory networks by multisite protein modifications. Trends Cell Biol. 20, 634-641.
199. Sardanelli, A. M., Signorile, A., Nuzzi R.,Rasmo,D.D.,TechnikovaDobrova, Z., Drahota, Z., Occhiello, A., Pica, A., and Papa, S. (2006). Occurrence of A-kinase anchor protein and associated cAMPdependent protein kinase in the inner compartment of mammalian mitochondria. FEBS Lett. 580, 5690-5696.
200. Sassi, N., Biasutto, L., Mattarei A.,Carraro,M.,Giorgio,V., Citta, A., Bernardi, P., Garbisa, S., Szabo, I., Paradisi, C., and Zoratti, M. (2012). Cytotoxicity of a mitochondriotropic quercetin derivative: Mechanisms. Biochim. Biophys. Acta. 1817, 1095-1106.
201. Sauer, U. (2006). Metabolic networks in motion: 13C-based flux analysis. Mol. Syst. Biol. 2, 62.
202. Schaber, J., Flöttmann, M., Li, J., Tiger, C., Hohmann, S., and Klipp, E. (2011). Automated ensemble modeling with modelMaGe: analyzing feedback mechanisms in the Sho1 branch of the HOG pathway. PLoS ONE 6:e14791. doi: 10.1371/ journal.pone.0014791
203. Schatz, G. (2007). The magic garden. Annu. Rev. Biochem. 76, 673-678.
204. Schmidt, A., Kalkhof, S., Ihling, C., Cooper, D. M., and Sinz, A. (2005). Mapping protein interfaces by chemical crosslinking and Fourier transform ion cyclotron resonance mass spectrometry: application to a calmodulin/adenylyl cyclase 8 peptide complex. Eur. J. Mass Spectrom. (Chichester, Eng.). 11, 525-534.
205. Serkova, N., and Boros, L. G. (2005). Detection of resistance to imatinib by metabolic profiling: clinical and drug development implications. Am.J.Pharmacogenomics5, 293-302.
206. Serrano, M., Lin, A. W., McCurrach M.E.,Beach,D.,andLowe,S. W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602.
207. Shankar, L. K., Hoffman, J. M., Bacharach, S., Graham, M. M., Karp, J., Lammertsma, A. A., Larson, S., Mankoff, D. A., Siegel, B. A., Van den Abbeele, A., Yap, J., and Sullivan, D. (2006). Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J. Nucl. Med. 47, 1059-1066.
208. Shidara, Y., Yamagata, K., Kanamori, T., Nakano, K., Kwong, J. Q., Manfredi, G., Oda, H., and Ohta, S. (2005). Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 65, 1655-1663.
209. Shiraishi, T., Matsuyama, S., and Kitano, H. (2010). Large-scale analysis of network bistability for human cancers. PLoS Comput. Biol. 6:e1000851. doi: 10.1371/journal.pcbi.1000851
210. Shoemaker, R. H. (2006). The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer 6, 813-823.
211. Shoshan-Barmatz, V., and Golan, M. (2012). Mitochondrial VDAC1, function in cell life and death and a target for cancer therapy. Curr. Med. Chem. 19, 714-735.
212. Sibson, N. R., Dhankhar, A., Mason, G. F., Behar, K. L., Rothman, D. L., and Shulman, R. G. (1997). In vivo 13C NMR measurements of cerebral glutamine synthesis as evidence for glutamate-glutamine cycling. Proc. Natl. Acad. Sci. U.S.A. 94, 2699-2704.
213. Smith, A. C., Blackshaw, J. A., and Robinson, A. J. (2012). MitoMiner: a data warehouse for mitochondrial proteomics data. Nucleic Acids Res. 40, D1160-D1167.
214. Smith, A. C., and Robinson, A. J. (2011). A metabolic model of the mitochondrion and its use in modelling diseases of the tricarboxylic acid cycle. BMC Syst. Biol. 5, 102.
215. Smolka, M., Zhou, H., and Aebersold, R. (2002). Quantitative protein profiling using two-dimensional gel electrophoresis, isotope-coded affinity tag labeling, and mass spectrometry. Mol. Cell Proteomics 1, 19-29.
216. Soloviev, D., Lewis, D., Honess, D., and Aboagye, E. (2012). [(18)F]FLT: an imaging biomarker of tumour proliferation for assessment of tumour response to treatment. Eur. J. Cancer 48, 416-424.
217. Spratlin,J.L.,Serkova,N.J.,and Eckhardt, S. G. (2009). Clinical applications of metabolomics in oncology: a review. Clin. Cancer Res. 15, 431-440.
218. Stephanopoulos, G. (1999). Metabolic fluxes and metabolic engineering. Metab. Eng. 1, 1-11.
219. Stevens, E. V., Posadas, E. M., Davidson, B., and Kohn, E. C. (2004). Proteomics in cancer. Ann. Oncol. 15(Suppl. 4), iv167-iv171.
220. Stewart, S., and Guan, K. L. (2000). The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation. J. Biol. Chem. 275, 8854-8862.
221. Strong, R., Nakanishi, T., Ross, D., and Fenselau, C. (2006). Alterations in the mitochondrial proteome of adriamycin resistant MCF-7 breast cancer cells. J. Proteome Res. 5, 2389-2395.
222. Sunaga, N., Oriuchi, N., Kaira, K., Yanagitani, N., Tomizawa, Y., Hisada, T., Ishizuka, T., Endo, K., and Mori, M. (2008). Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer. Lung Cancer 59, 203-210.
223. Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., Sugano, S., Sato, E., Nagao, T., Yokote, K., Tatsuno, I., and Prives, C. (2010). Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 107, 7461-7466.
224. Technikova-Dobrova, Z., Sardanelli A.M.,Speranza,F.,Scacco,S., Signorile, A., Lorusso, V., and Papa, S. (2001). Cyclic adenosine monophosphate-dependent phosphorylation of mammalian mitochondrial proteins: enzyme and substrate characterization and functional role. Biochemistry 40, 13941-13947.
225. ter Kuile, B. H., and Westerhoff, H. V. (2001). Transcriptome meets metabolome: hierarchical and metabolic regulation of the glycolytic pathway. FEBS Lett. 500, 169-171.
226. Tran, J. C., Zamdborg, L., Ahlf, D. R., Lee, J. E., Catherman, A. D., Durbin K.R.,Tipton,J.D.,Vellaichamy, A., Kellie, J. F., Li, M., Wu, C., Sweet, S. M., Early, B. P., Siuti, N., LeDuc, R. D., Compton, P. D., Thomas, P. M., and Kelleher, N. L. (2011). Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature 480, 254-258.
227. Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W., Lu, C., Ward, P. S., Thompson, C. B., Kaufman, A., Guryanova, O., Levine, R., Heguy, A., Viale, A., Morris, L. G., Huse, J. T., Mellinghoff, I. K., and Chan, T. A. (2012). IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479-483.
228. van de Vijver, M. J., He, Y. D., van't Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton M.J.,Parrish,M.,Atsma,D., Witteveen, A., Glas, A., Delahaye, L., van der Velde, T., Bartelink, H., Rodenhuis, S., Rutgers, E. T. Friend,S.H.,andBernards,R. (2002). A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009.
229. Vanoni, M., Bertini, R., Sacco, E., Fontanella, L., Rieppi, M., Colombo, S., Martegani, E., Carrera, V., Moroni, A., Bizzarri, C., Sabbatini, V., Cattozzo, M., Colagrande, A., and Alberghina, L. (1999). Characterization and properties of dominant-negative mutants of the ras-specific guanine nucleotide exchange factor CDC25(Mm). J. Biol. Chem. 274, 36656-36662.
230. Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U. Monzon, F. A., Becich, M. J., Wei, J. T., Pienta, K. J., Ghosh, D., Rubin M.A.,andChinnaiyan,A.M. (2005). Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393-406.
231. Vlashi, E., Lagadec, C., Vergnes, L., Matsutani, T., Masui, K., Poulou M.,Popescu,R.,DellaDonna, L., Evers, P., Dekmezian, C., Reue, K., Christofk, H., Mischel, P. S., and Pajonk, F. (2011). Metabolic state of glioma stem cells and nontumorigenic cells. Proc. Natl. Acad. Sci. U.S.A. 108, 16062-16067.
232. von Eggeling, F., Davies, H., Lomas, L., Fiedler, W., Junker, K., Claussen, U., and Ernst, G. (2000). Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques 29, 1066-1070.
233. Vousden, K. H. (2010). Alternative fuel-another role for p53 in the regulation of metabolism. Proc. Natl. Acad. Sci. U.S.A. 107, 7117-7118.
234. Wallace, D. C. (1999). Mitochondrial diseases in man and mouse. Science 283, 1482-1488.
235. Wallace, D. C. (2005). A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359-407.
236. Walther, J. L., Metallo, C. M., Zhang, J., and Stephanopoulos, G. (2012). Optimization of (13)C isotopic tracers for metabolic flux analysis in mammalian cells. Metab. Eng. 14, 162-171.
237. Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts,A.M.,Look,M.P.,Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., Jatkoe, T., Berns, E. M., Atkins, D., and Foekens, J. A. (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671-679.
238. Wang, Z. Y., Loo, T. Y., Shen, J. G., Wang, N., Wang, D. M., Yang D.P.,Mo,S.L.,Guan,X.Y., and Chen, J. P. (2011). LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis. Breast Cancer Res. Treat. 131, 791-800.
239. Warburg,O.,Wind,F.,andNegelein,E. (1927). The metabolism of tumors in the body. J. Gen. Physiol. 8, 519-530.
240. Ward,P.S.,andThompson,C.B. (2012). Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21, 297-308.
241. Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R., and Chandel, N. S. (2010). Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl. Acad. Sci. U.S.A. 107, 8788-8793.
242. Weinberg, R. (2007). The Biology of Cancer.NewYork,NY:Garland Science.
243. Wellen, K. E., and Thompson, C. B. (2012). A two-way street: reciprocal regulation of metabolism and signalling. Nat. Rev. Mol. Cell Biol. 13, 270-276.
244. Wellstead, P., and Cloutier, M. (2011). An energy systems approach to Parkinson's disease. Wiley Interdiscip. Rev. Syst. Biol. Med. 3, 1-6.
245. Wiechert, W. (2001). 13C metabolic flux analysis. Metab. Eng. 3, 195-206.
246. Wise,D.R.,andThompson,C.B. (2010). Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 35, 427-433.
247. Wise,D.R.,Ward,P.S.,Shay,J. E., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo,R.G.,Simon,M.C.,and Thompson, C. B. (2011). Hypoxia promotes isocitrate dehydrogenasedependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. U.S.A. 108, 19611-19616.
248. Wu, F., Yang, F., Vinnakota, K. C., and Beard, D. A. (2007a). Computer modeling of mitochondrial tricarboxylic acid cycle, oxidative phosphorylation, metabolite transport, and electrophysiology. J. Biol. Chem. 282, 24525-24537.
249. Wu,M.,Neilson,A.,Swift,A.L., Moran, R., Tamagnine, J., Parslow, D., Armistead, S., Lemire, K. Orrell,J.,Teich,J.,Chomicz, S., and Ferrick, D. A. (2007b). Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell Physiol. 292, C125-C136.
250. Wu,H.,Liu,T.,Ma,C.,Xue,R., Deng, C., Zeng, H., and Shen, X. (2011). GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization. Anal. Bioanal. Chem. 401, 635-646.
251. Wu, M. (2009). Methods in cancer metabolism: real-time measurement of mitochondrial respiration and glycolysis rates of cancer cells in a microplate. Am. Assoc. Cancer Res. Educ. Book 295-300.
252. Xu,X.,Qiao,M.,Zhang,Y.,Jiang,Y., Wei, P., Yao, J., Gu, B., Wang, Y., Lu, J.,Wang,Z.,Tang,Z.,Sun,Y.,Wu, W., and Shi, Q. (2010). Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer. Proteomics 10, 1374-1390.
253. Yates,J.R.,Ruse,C.I.,andNakorchevsky, A. (2009). Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 11, 49-79.
254. Yi, C. H., Pan, H., Seebacher, J., Jang, I. H., Hyberts, S. G., Heffron, G. J., Vander Heiden, M. G., Yang, R., Li, F., Locasale, J. W., Sharfi, H., Zhai, B., Rodriguez-Mias, R., Luithardt, H., Cantley, L. C., Daley G.Q.,Asara,J.M.,Gygi,S.P., Wagner, G., Liu, C. F., and Yuan, J. (2011). Metabolic regulation of protein N-alpha-acetylation by BclxL promotes cell survival. Cell 146, 607-620.
255. Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., FletcherSananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., Yan, H., Wang, W., Chen, S., Viale, A., Zheng, H., Paik, J. H., Lim C.,Guimaraes,A.R.,Martin,E. S., Chang, J., Hezel, A. F., Perry, S. R., Hu, J., Gan, B., Xiao, Y., Asara, J. M., Weissleder, R., Wang, Y. A., Chin, L., Cantley, L. C., and Depinho, R. A. (2012). Oncogenic kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell 149, 656-670.
256. Young, A. R., Narita, M., Ferreira M.,Kirschner,K.,Sadaie,M., Darot, J. F., Tavare, S., Arakawa S.,Shimizu,S.,Watt,F.M.,and Narita, M. (2009). Autophagy mediates the mitotic senescence transition. Genes Dev. 23, 798-803.
257. Yugi, K. and Tomita, M. (2004). A general computational model of mitochondrial metabolism in a whole organellescale. Bioinformatics 20,1795-1796.
258. Yuneva, M. (2008). Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells. Cell Cycle 7, 2083-2089.
259. Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R., and Lazebnik, Y. (2007). Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 178, 93-105.
260. Zhang, X., Ye, J., Engholm-Keller, K., and Hojrup, P. (2011). A proteome-scale study on in vivo protein Nalpha-acetylation using an optimized method. Proteomics 11, 81-93.
261. Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., Li, Y., Shi, J., An, W.,Hancock,S.M.,He,F.,Qin,L., Chin, J., Yang, P., Chen, X., Lei, Q., Xiong, Y., and Guan, K. L. (2010). Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004.
262. Zippin, J. H., Chen, Y., Nahirney, P., Kamenetsky, M., Wuttke M.S.,Fischman,D.A.,Levin, L. R., and Buck, J. (2003). Compartmentalization of bicarbonate-sensitive adenylyl cyclase in distinct signaling microdomains. FASEB J. 17, 82-84.